Completely intrafascial group | Conventional interfascial group | P value | |
---|---|---|---|
No. pts. | 20 | 24 | – |
Mean mon follow-up (SD) | 15.7 (4.4) | 22.2 (7.5) | 0.001 |
Mean yrs age (SD) | 66.2 (9.5) | 61.8 (9.8) | 0.149 |
Mean kg/m2 BMI (SD) | 24.7 (3.7) | 24.3 (4.4) | 0.749 |
No. smoking (%) | 8 (40.0) | 11 (45.8) | 0.697 |
No. hypertension (%) | 8 (40.0) | 6 (25.0) | 0.287 |
No. diabetes (%) | 7 (35.0) | 9 (37.5) | 0.864 |
No. NAC (%) | 6 (30.0) | 7 (29.2) | 0.952 |
No. surgery type (%) | 0.895 | ||
open | 1 (5.0) | 1 (4.2) | |
aparoscopic | 19 (95.0) | 21 (95.8) | |
No. diversion type (%) | 0.544 | ||
orthotopic neobladder | 13 (65.0) | 19 (79.2) | |
ileal conduit | 5 (25.0) | 4 (16.7) | |
ureterocutaneostomy | 2 (10.0) | 1 (4.2) | |
Mean mins operation duration (SD) | 339.4 (46.1) | 343.9 (40.5) | 0.731 |
Mean ml estimated blood loss (SD) | 518.3 (383.9) | 565.8 (382.3) | 0.684 |
Mean pre-operative IIEF-5 score (SD) | 16.3 (3.8) | 17.1 (4.5) | 0.539 |
No. pre-operative sexual function (%) | 0.264 | ||
normal sexual function | 3 (15.0) | 7 (29.2) | |
mild erectile dysfunction | 17 (85.0) | 17 (70.8) | |
No. dead pts. during follow-up (%) | 1 (5.0) | 0 (0) | 0.268 |
No. missing pts. during follow-up (%) | 2 (10.0) | 2 (8.3) | 0.848 |